Toho Holdings Co., Ltd. (8129.T)
JPY 4770.0
(-0.44%)
JPY 4770.0
(-0.44%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 523.98 Billion JPY | 10.93% |
| 2022 | 472.37 Billion JPY | 2.45% |
| 2021 | 461.09 Billion JPY | 3.44% |
| 2020 | 445.77 Billion JPY | 1.35% |
| 2019 | 439.82 Billion JPY | -2.24% |
| 2018 | 449.88 Billion JPY | 2.54% |
| 2017 | 438.74 Billion JPY | 6.85% |
| 2016 | 410.6 Billion JPY | -12.27% |
| 2015 | 468.04 Billion JPY | 5.75% |
| 2014 | 442.58 Billion JPY | 2.22% |
| 2013 | 432.94 Billion JPY | 1.06% |
| 2012 | 428.39 Billion JPY | 3.27% |
| 2011 | 414.84 Billion JPY | 1.81% |
| 2010 | 407.47 Billion JPY | 4.85% |
| 2009 | 388.61 Billion JPY | 21.35% |
| 2008 | 320.24 Billion JPY | 4.48% |
| 2007 | 306.5 Billion JPY | -4.12% |
| 2006 | 319.65 Billion JPY | 8.1% |
| 2005 | 295.69 Billion JPY | 8.45% |
| 2004 | 272.65 Billion JPY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 519.83 Billion JPY | -0.79% |
| 2023 Q2 | 556.23 Billion JPY | 12.74% |
| 2023 Q3 | 561.16 Billion JPY | 0.89% |
| 2023 Q4 | 523.98 Billion JPY | -6.63% |
| 2023 Q1 | 493.36 Billion JPY | 4.44% |
| 2023 FY | 523.98 Billion JPY | 10.93% |
| 2022 Q2 | 495.01 Billion JPY | 6.15% |
| 2022 FY | 472.37 Billion JPY | 2.45% |
| 2022 Q4 | 472.37 Billion JPY | -14.73% |
| 2022 Q1 | 466.31 Billion JPY | 1.13% |
| 2022 Q3 | 554 Billion JPY | 11.92% |
| 2021 Q3 | 493.08 Billion JPY | 8.33% |
| 2021 Q1 | 460.03 Billion JPY | 3.2% |
| 2021 Q2 | 455.18 Billion JPY | -1.05% |
| 2021 FY | 461.09 Billion JPY | 3.44% |
| 2021 Q4 | 461.09 Billion JPY | -6.49% |
| 2020 Q2 | 445.37 Billion JPY | 1.19% |
| 2020 Q1 | 440.11 Billion JPY | 0.07% |
| 2020 FY | 445.77 Billion JPY | 1.35% |
| 2020 Q4 | 445.77 Billion JPY | -6.9% |
| 2020 Q3 | 478.82 Billion JPY | 7.51% |
| 2019 Q4 | 439.82 Billion JPY | -8.45% |
| 2019 FY | 439.82 Billion JPY | -2.24% |
| 2019 Q3 | 480.41 Billion JPY | 12.43% |
| 2019 Q1 | 457.3 Billion JPY | 1.65% |
| 2019 Q2 | 427.31 Billion JPY | -6.56% |
| 2018 Q3 | 481.76 Billion JPY | 7.86% |
| 2018 Q4 | 449.88 Billion JPY | -6.62% |
| 2018 Q2 | 446.65 Billion JPY | -3.38% |
| 2018 Q1 | 462.29 Billion JPY | 5.37% |
| 2018 FY | 449.88 Billion JPY | 2.54% |
| 2017 Q3 | 474.64 Billion JPY | 7.72% |
| 2017 Q2 | 440.64 Billion JPY | 4.11% |
| 2017 Q1 | 423.25 Billion JPY | 3.08% |
| 2017 FY | 438.74 Billion JPY | 6.85% |
| 2017 Q4 | 438.74 Billion JPY | -7.56% |
| 2016 Q4 | 410.6 Billion JPY | -13.14% |
| 2016 Q3 | 472.73 Billion JPY | 13.1% |
| 2016 FY | 410.6 Billion JPY | -12.27% |
| 2016 Q2 | 417.99 Billion JPY | -8.32% |
| 2016 Q1 | 455.95 Billion JPY | -2.58% |
| 2015 FY | 468.04 Billion JPY | 5.75% |
| 2015 Q1 | 433.64 Billion JPY | -2.02% |
| 2015 Q2 | 441.15 Billion JPY | 1.73% |
| 2015 Q3 | 535.86 Billion JPY | 21.47% |
| 2015 Q4 | 468.04 Billion JPY | -12.66% |
| 2014 Q4 | 442.58 Billion JPY | -7.81% |
| 2014 FY | 442.58 Billion JPY | 2.22% |
| 2014 Q1 | 415.01 Billion JPY | -4.14% |
| 2014 Q3 | 480.09 Billion JPY | 18.34% |
| 2014 Q2 | 405.69 Billion JPY | -2.25% |
| 2013 FY | 432.94 Billion JPY | 1.06% |
| 2013 Q2 | 415.85 Billion JPY | -4.3% |
| 2013 Q1 | 434.56 Billion JPY | 1.44% |
| 2013 Q3 | 471.61 Billion JPY | 13.41% |
| 2013 Q4 | 432.94 Billion JPY | -8.2% |
| 2012 Q3 | 439.6 Billion JPY | 9.4% |
| 2012 Q1 | 419.08 Billion JPY | 1.02% |
| 2012 Q2 | 401.82 Billion JPY | -4.12% |
| 2012 FY | 428.39 Billion JPY | 3.27% |
| 2012 Q4 | 428.39 Billion JPY | -2.55% |
| 2011 Q4 | 414.84 Billion JPY | -6.93% |
| 2011 Q3 | 445.73 Billion JPY | 11.13% |
| 2011 FY | 414.84 Billion JPY | 1.81% |
| 2011 Q2 | 401.08 Billion JPY | -1.41% |
| 2011 Q1 | 406.82 Billion JPY | -0.16% |
| 2010 Q3 | 436.32 Billion JPY | 12.56% |
| 2010 Q1 | 408.23 Billion JPY | 5.05% |
| 2010 Q2 | 387.63 Billion JPY | -5.05% |
| 2010 FY | 407.47 Billion JPY | 4.85% |
| 2010 Q4 | 407.47 Billion JPY | -6.61% |
| 2009 Q2 | 368.18 Billion JPY | 0.0% |
| 2009 FY | 388.61 Billion JPY | 21.35% |
| 2009 Q3 | 431 Billion JPY | 17.06% |
| 2009 Q4 | 388.61 Billion JPY | -9.84% |
| 2008 Q4 | 320.24 Billion JPY | -5.72% |
| 2008 FY | 320.24 Billion JPY | 4.48% |
| 2008 Q3 | 339.66 Billion JPY | 0.0% |
| 2007 FY | 306.5 Billion JPY | -4.12% |
| 2006 FY | 319.65 Billion JPY | 8.1% |
| 2005 FY | 295.69 Billion JPY | 8.45% |
| 2004 FY | 272.65 Billion JPY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 24.98 Billion JPY | -1996.955% |
| Takeda Pharmaceutical Company Limited | 7834.78 Billion JPY | 93.312% |
| Sumitomo Pharma Co., Ltd. | 751.37 Billion JPY | 30.262% |
| Shionogi & Co., Ltd. | 164.35 Billion JPY | -218.816% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.39 Billion JPY | -15334.175% |
| Nippon Shinyaku Co., Ltd. | 42.86 Billion JPY | -1122.327% |
| Kaken Pharmaceutical Co., Ltd. | 27.86 Billion JPY | -1780.381% |
| Eisai Co., Ltd. | 494.82 Billion JPY | -5.893% |
| Morishita Jintan Co., Ltd. | 5.04 Billion JPY | -10296.567% |
| Hisamitsu Pharmaceutical Co., Inc. | 61.69 Billion JPY | -749.332% |
| Mochida Pharmaceutical Co., Ltd. | 30.83 Billion JPY | -1599.491% |
| Fuso Pharmaceutical Industries,Ltd. | 39.79 Billion JPY | -1216.749% |
| Nippon Chemiphar Co., Ltd. | 31.08 Billion JPY | -1585.713% |
| Tsumura & Co. | 132.88 Billion JPY | -294.313% |
| Kissei Pharmaceutical Co., Ltd. | 39.79 Billion JPY | -1216.848% |
| Torii Pharmaceutical Co., Ltd. | 13.29 Billion JPY | -3840.641% |
| Towa Pharmaceutical Co., Ltd. | 274.75 Billion JPY | -90.709% |
| Fuji Pharma Co., Ltd. | 44.15 Billion JPY | -1086.619% |
| Zeria Pharmaceutical Co., Ltd. | 70.7 Billion JPY | -641.091% |
| KYORIN Holdings, Inc. | 46.89 Billion JPY | -1017.41% |
| Taiko Pharmaceutical Co.,Ltd. | 7 Billion JPY | -7382.322% |
| Daito Pharmaceutical Co.,Ltd. | 25.43 Billion JPY | -1959.778% |
| SymBio Pharmaceuticals Limited | 8.14 Billion JPY | -6335.499% |
| MedRx Co., Ltd | 129 Million JPY | -406091.473% |
| Mizuho Medy Co.,Ltd. | 3.27 Billion JPY | -15911.655% |
| Solasia Pharma K.K. | 673 Million JPY | -77758.395% |
| Modalis Therapeutics Corporation | 645.5 Million JPY | -81074.991% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 31.38 Billion JPY | -1569.759% |
| Sawai Group Holdings Co., Ltd. | 163.99 Billion JPY | -219.516% |
| Cyfuse Biomedical K.K. | 1.01 Billion JPY | -51711.161% |
| Koa Shoji Holdings Co.,Ltd. | 6.95 Billion JPY | -7436.845% |